Vasyl Vasko
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 21
-
- Metabolism, Diabetes, and Cancer 6
- bioluminescence and chemiluminescence research 2
- Co-authors
- Motoyasu Saji (6 shared papers)Kirk Jensen (24 shared papers)Aneeta Patel (19 shared papers)Joanna Kłubo-Gwieździńska (16 shared papers)Kenneth D. Burman (18 shared papers)Matthew D. Ringel (4 shared papers)Paul E. Wakely (3 shared papers)Minden Collamore (2 shared papers)
- Journals
- Endocrine Related Cancer (6 papers)Thyroid (5 papers)Cancers (4 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesAlbaniaPoland
In The Last Decade
Vasyl Vasko
38 papers receiving 1.7k citations
Vasyl Vasko's Hit Papers
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 826
- Oncology 456
- Cancer Research 238
- Molecular Biology 582
- Genetics 61
Countries citing papers authored by Vasyl Vasko
This map shows the geographic impact of Vasyl Vasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasyl Vasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasyl Vasko more than expected).
Fields of papers citing papers by Vasyl Vasko
This network shows the impact of papers produced by Vasyl Vasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasyl Vasko. The network helps show where Vasyl Vasko may publish in the future.
Co-authors
The 25 scholars most cited alongside Vasyl Vasko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Sorafenib in Metastatic Thyroid Cancer Hit paper breakdown → | 2009 | 430 |
| 2 | 2010 | 288 | |
| 3 | 2018 | 111 | |
| 4 | 2013 | 94 | |
| 5 | 2012 | 72 | |
| 6 | 2006 | 63 | |
| 7 | 2012 | 51 | |
| 8 | 2015 | 50 | |
| 9 | 2010 | 36 | |
| 10 | 2016 | 31 | |
| 11 | 2009 | 29 | |
| 12 | 2017 | 27 | |
| 13 | 2011 | 27 | |
| 14 | 2014 | 27 | |
| 15 | 2020 | 26 | |
| 16 | 2010 | 26 | |
| 17 | 2019 | 25 | |
| 18 | 2020 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2010 | 22 |
About Vasyl Vasko
Vasyl Vasko is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (21 papers), Cancer-related Molecular Pathways (8 papers), Metabolism, Diabetes, and Cancer (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), BRCA gene mutations in cancer (3 papers), Genetic factors in colorectal cancer (3 papers), Cancer Genomics and Diagnostics (2 papers) and bioluminescence and chemiluminescence research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (826 citations), Oncology (456 citations), Cancer Research (238 citations), Molecular Biology (582 citations) and Genetics (61 citations). Vasyl Vasko has collaborated with scholars based in United States, Albania and Poland. Frequent co-authors include Motoyasu Saji, Kirk Jensen, Aneeta Patel, Joanna Kłubo-Gwieździńska, Kenneth D. Burman, Matthew D. Ringel, Paul E. Wakely, Minden Collamore, Daria Arbogast and Michael V. Knopp. Their work appears in journals such as Endocrine Related Cancer, Thyroid, Cancers, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.